Validation of an HPLC–MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical Practice

Validation of an HPLC–MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical Practice

Ticagrelor is an antiplatelet agent which is extensively metabolized in an active metabolite: AR-C124910XX. Ticagrelor antagonizes P2Y12 receptors, but recently, this effect on the central nervous system has been linked to the development of dyspnea. Ticagrelor-related dyspnea has been linked to per...

Full description

Bibliographic Details
Main Authors:	Jennifer Lagoutte-Renosi, Bernard Royer, Vahideh Rabani, Siamak Davani
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Molecules
Subjects:	ticagrelor antiplatelet agents high performance liquid chromatography tandem mass spectrometry adverse events therapeutic drug monitoring
Online Access:	https://www.mdpi.com/1420-3049/26/2/278

Similar Items

Influence of Antiplatelet Agents on the Lipid Composition of Platelet Plasma Membrane: A Lipidomics Approach with Ticagrelor and Its Active Metabolite
by: Jennifer Lagoutte-Renosi, et al.
Published: (2021-01-01)

Chemical characterization of the photodegradation products of midazolam complexes with randomly methylated-β-cyclodextrin by HPLC and LC-MS/MS
by: Agatonovic-Kustrin Snezana, et al.
Published: (2016-01-01)

LC-MS/MS in proteomics : methods and applications /
by: Cutillas, Pedro R., et al.
Published: (c201)

Comparison of EI-GC-MS/MS, APCI-LC-MS/MS, and ESI-LC-MS/MS for the Simultaneous Analysis of Nine Nitrosamines Eluted from Synthetic Resins into Artificial Saliva and Health Risk Assessment
by: Hyungsoo Kim, et al.
Published: (2021-09-01)

Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane
by: Vahideh Rabani, et al.
Published: (2018-10-01)

Simultaneous quantitation of multiple myeloma related dietary metabolites in serum using HILIC-LC-MS/MS
by: Mo Wang, et al.
Published: (2023-07-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Validation of the LC-MS/MS method for the quantification of mevalonic acid in human plasma and determination of the matrix effect
by: G.S. Saini, et al.
Published: (2006-10-01)

Quantification of seminolipid by LC-ESI-MS/MS-multiple reaction monitoring: compensatory levels in Cgt mice[S]
by: Kessiri Kongmanas, et al.
Published: (2010-12-01)

Method Development and Validation for Simultaneous Analysis of Eleven Components for Quality Control of Geumgwesingihwan Using HPLC–DAD and UPLC–MS/MS
by: Chang-Seob Seo, et al.
Published: (2022-08-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Factors Determining Ticagrelor-Induced Dyspnea in Patients with Acute Coronary Syndrome
by: Vytenis Tamakauskas, et al.
Published: (2022-10-01)

Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice
by: Tommaso Ceruti, et al.
Published: (2022-09-01)

Quick and Sensitive UPLC-ESI-MS/MS Method for Simultaneous Estimation of Sofosbuvir and Its Metabolite in Human Plasma
by: Mohammad H. Semreen, et al.
Published: (2019-04-01)

Lipemia in the Plasma Sample Affects Fentanyl Measurements by Means of HPLC-MS<sup>2</sup> after Liquid-Liquid Extraction
by: Marta Tikhomirov, et al.
Published: (2021-07-01)

Determination of chloramphenicol antibiotics and their metabolite in soil by UPLC-MS/MS
by: Xulei MI, et al.
Published: (2023-04-01)

Determination of Diphenylamine in Gunshot Residue by HPLC-MS/MS
by: Hongcheng Mei, et al.
Published: (2016-01-01)

DMS as an orthogonal separation to LC/ESI/MS/MS for quantifying isomeric cerebrosides in plasma and cerebrospinal fluid[S]
by: Hongbin Xu, et al.
Published: (2019-01-01)

Application of large volume injection for sensitive LC-MS/MS analysis of seven artificial sweeteners in surface waters
by: Jonas Henschel, et al.
Published: (2020-01-01)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
by: Moazez J. Marian, et al.
Published: (2017-11-01)

Targeted Metabolomics: The LC-MS/MS Based Quantification of the Metabolites Involved in the Methylation Biochemical Pathways
by: Georgia Ntasi, et al.
Published: (2021-06-01)

Enantioseparation and Determination of Penconazole in Rat Plasma by Chiral LC-MS/MS: Application to a Stereoselective Toxicokinetic Study
by: Siman Ma, et al.
Published: (2020-06-01)

Global metabolite profiling based on GC–MS and LC–MS/MS analyses in ABF3-overexpressing soybean with enhanced drought tolerance
by: Kyong-Hee Nam, et al.
Published: (2019-03-01)

Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS
by: Natalia Starodubtseva, et al.
Published: (2023-01-01)

Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischemic risk compared with 75–100 mg aspirin daily in coronary artery disease patients: insights from the TIFU (Ticagrelor in Fuwai Hospital) study
by: Jiannan Li, et al.
Published: (2020-08-01)

HPLC-MS/MS coupled with equilibrium dialysis method for quantification of free drug concentration of pazopanib in plasma
by: Yi Long Toh, et al.
Published: (2020-04-01)

High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS
by: Maria Blomqvist, et al.
Published: (2017-07-01)

A life-threatening massive hemoptysis case in the course of dual antiplatelet therapy with ticagrelor
by: Dimitrios Molyvas, et al.
Published: (2022-09-01)

Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial
by: Byung Gyu Kim, et al.
Published: (2021-12-01)

LC-MS/MS Estimation of Propranolol level in Exhaled Breath Condensate
by: Samin Hamidi 1, Maryam Amini 2, Maryam Khoubnasabjafari 3, Vahid Jouyban-Gharamaleki 4,5, Hossein Sate 6, Abolghasem Jouyban 5,7 *
Published: (2017-12-01)

Characterization of Polyphenolic Composition of Extracts from Winery Wastes by HPLC-UV-MS/MS
by: Iris Carretero, et al.
Published: (2021-10-01)

Comparison of In-Hospital Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction Treated with Ticagrelor or Clopidogrel in the Emergency Department: A Propensity Score Matched Retrospective Cohort Study
by: Po-Yao Huang, et al.
Published: (2023-08-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
by: Yunyan Pan, et al.
Published: (2024-04-01)

Identification of unusual phospholipids from bovine heart mitochondria by HPLC-MS/MS
by: Junhwan Kim, et al.
Published: (2020-12-01)

Development of a Rapid LC-MS/MS Method for the Determination of Emerging Fusarium mycotoxins Enniatins and Beauvericin in Human Biological Fluids
by: Ana Belén Serrano, et al.
Published: (2015-09-01)

Determination of Bioactive Components in Chinese Herbal Formulae and Pharmacokinetics of Rhein in Rats by UPLC-MS/MS
by: Mei-Ling Hou, et al.
Published: (2014-04-01)

HPLC-MS Analysis of Chloramphenicol Residues in Milk and Powdered Milk Products
by: Bošnir, J., et al.
Published: (2007-02-01)

Assessment of the Polyphenolic Composition of Orange Waste from Agri-Food Industries by HPLC-UV-MS/MS
by: Àlex Cáceres, et al.
Published: (2021-10-01)

Ticagrelor versus clopidogrel after intracranial stent angioplasty: a real-world study
by: Lili Sun, et al.
Published: (2023-08-01)